Patrys Ltd. | Income Statement

Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
-
-
275.00
53.30
27.50
Cost of Goods Sold (COGS) incl. D&A
544.80
603.60
-
-
-
Gross Income
544.80
603.60
-
-
-
SG&A Expense
7,495.80
5,044.30
1,976.90
2,365.70
2,969.90
EBIT
8,040.60
5,647.90
1,722.00
2,360.00
2,990.30
Unusual Expense
-
4,086.30
-
-
-
Non Operating Income/Expense
-
321.20
61.90
847.40
4.00
Pretax Income
7,863.50
9,283.40
1,583.30
1,468.00
2,952.50
Income Tax
574.40
813.10
502.50
410.20
455.20
Consolidated Net Income
7,289.10
8,470.40
1,080.80
1,057.90
2,497.30
Net Income
7,289.10
8,470.40
1,080.80
1,057.90
2,497.30
Net Income After Extraordinaries
7,289.10
8,470.40
1,080.80
1,057.90
2,497.30
Net Income Available to Common
7,289.10
8,470.40
1,080.80
1,057.90
2,497.30
EPS (Basic)
0.01
0.01
0.00
0.00
0.00
Basic Shares Outstanding
622,860.90
717,133.50
735,384.90
771,879.10
941,191.60
EPS (Diluted)
0.01
0.01
0.00
0.00
0.00
Diluted Shares Outstanding
622,860.90
717,133.50
735,384.90
771,879.10
941,191.60
EBITDA
7,495.80
5,044.30
1,701.90
2,312.40
2,942.50
Non-Operating Interest Income
177.10
129.50
76.90
44.50
33.80

About Patrys

View Profile
Address
Level 4
South Melbourne Victoria (VIC) 3204
Australia
Employees -
Website http://www.patrys.com
Updated 07/08/2019
Patrys Ltd. engages in the commercialisation of the group's proprietary technologies to develop natural human antibody-based therapeutic products for the treatment of cancer and the pursuit of non-dilutive funding sources. It develops natural human antibody-based therapeutic products for the treatment of cancer. The company was founded by Daniel Devine on December 8, 2006 and is headquartered in South Melbourne, Australia.